Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
LRCX Stock Summary
Top 10 Correlated ETFs
LRCX
In the News

Lam Research Corporation Announces September 2023 Quarter Financial Conference Call
FREMONT, Calif. , Sept. 27, 2023 /PRNewswire/ -- Lam Research Corp. (NASDAQ: LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, October 18, 2023, beginning at 2:00 p.m.

Is Lam Research Stock a Buy Now?
Technologies like AI and the desire to build more fabrication plants will undoubtedly boost Lam Research. Earnings will likely fall in the next fiscal year.

These 20 growth stocks are worth considering on a pullback, says Citi
Citi has released a list of 20 large-cap growth stocks that it says present opportunities in the event of a pullback.

Better AI Stock: Lam Research vs. Marvell Technology
Both companies are feeling the pinch from a downturn in storage investment. However, both have tantalizing upside from new AI chips and chipmaking techniques.

Is It Too Late to Buy Lam Research Stock?
Lam's growth slowed down significantly in fiscal 2023. The stock has risen in anticipation of its eventual cyclical recovery.

Is Lam Research (LRCX) Stock Outpacing Its Computer and Technology Peers This Year?
Here is how Lam Research (LRCX) and Super Micro Computer (SMCI) have performed compared to their sector so far this year.

New Strong Buy Stocks for September 18th
WRK, ATR, BY, LRCX and STIX have been added to the Zacks Rank #1 (Strong Buy) List on September 18, 2023.

Best Income Stocks to Buy for September 18th
WRK, LRCX and DOLE made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 18, 2023.

7 Semiconductor Stocks to Buy for a U.S.-China Chip War
Although geopolitical conflicts between major economic powers are generally something to be avoided, for semiconductor stocks trading amid the backdrop of the U.S.-China chip war, the bad news just might be good news. With more than just competitive bragging rights involved, the technology sector has never been more crucial.

4 Semiconductor Stocks to Buy on Solid Rebound in Sales
The semiconductor industry is showing signs of recovery as sales are rebounding, which is helping stocks like ON Semiconductor Corporation (ON), NVIDIA Corporation (NVDA), ACM Research, Inc. (ACMR) and Lam Research Corporation (LRCX).
LRCX Financial details
LRCX Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-25
Metric | History | 2019-06-30 | 2020-06-28 | 2021-06-27 | 2022-06-26 | 2023-06-25 |
---|---|---|---|---|---|---|
Revenue per share | 63.31 | 69.36 | 101.85 | 123.14 | 128.65 | |
Net income per share | 14.37 | 15.55 | 27.22 | 32.92 | 33.3 | |
Operating cash flow per share | 20.83 | 14.68 | 24.99 | 22.16 | 38.23 | |
Free cash flow per share | 18.84 | 13.28 | 22.55 | 18.25 | 34.53 | |
Cash per share | 35.62 | 46.34 | 39.89 | 26.15 | 39.67 | |
Book value per share | 30.98 | 35.79 | 41.97 | 44.88 | 60.6 | |
Tangible book value per share | 18.39 | 23.22 | 29.75 | 33.32 | 47.38 | |
Share holders equity per share | 30.98 | 35.79 | 41.97 | 44.88 | 60.6 | |
Interest debt per share | 30.22 | 41.35 | 36.28 | 37.1 | 38.37 | |
Market cap | 29.18B | 44.67B | 92.91B | 62.93B | 84.04B | |
Enterprise value | 30.01B | 45.56B | 93.49B | 64.41B | 83.71B | |
P/E ratio | 13.31 | 19.84 | 23.77 | 13.66 | 18.63 | |
Price to sales ratio | 3.02 | 4.45 | 6.35 | 3.65 | 4.82 | |
POCF ratio | 9.19 | 21.01 | 25.89 | 20.3 | 16.23 | |
PFCF ratio | 10.16 | 23.23 | 28.68 | 24.64 | 17.97 | |
P/B Ratio | 6.18 | 8.62 | 15.42 | 10.02 | 10.24 | |
PTB ratio | 6.18 | 8.62 | 15.42 | 10.02 | 10.24 | |
EV to sales | 3.11 | 4.54 | 6.39 | 3.74 | 4.8 | |
Enterprise value over EBITDA | 10.82 | 15.49 | 19.52 | 11.27 | 14.94 | |
EV to operating cash flow | 9.45 | 21.43 | 26.06 | 20.78 | 16.16 | |
EV to free cash flow | 10.45 | 23.69 | 28.86 | 25.22 | 17.9 | |
Earnings yield | 0.08 | 0.05 | 0.04 | 0.07 | 0.05 | |
Free cash flow yield | 0.1 | 0.04 | 0.03 | 0.04 | 0.06 | |
Debt to equity | 0.95 | 1.12 | 0.83 | 0.8 | 0.61 | |
Debt to assets | 0.37 | 0.4 | 0.31 | 0.29 | 0.27 | |
Net debt to EBITDA | 0.3 | 0.3 | 0.12 | 0.26 | -0.06 | |
Current ratio | 3.61 | 3.43 | 3.3 | 2.69 | 3.16 | |
Interest coverage | 21.02 | 15.07 | 21.49 | 29.13 | 27.75 | |
Income quality | 1.45 | 0.94 | 0.92 | 0.67 | 1.15 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.31 | 0.29 | 0.19 | 0.18 | 0.2 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.12 | 0.12 | 0.1 | 0.09 | 0.1 | |
Intangibles to total assets | 0.14 | 0.11 | 0.1 | 0.09 | 0.1 | |
Capex to operating cash flow | -0.1 | -0.1 | -0.1 | -0.18 | -0.1 | |
Capex to revenue | -0.03 | -0.02 | -0.02 | -0.03 | -0.03 | |
Capex to depreciation | -0.98 | -0.76 | -1.14 | -1.64 | -1.46 | |
Stock based compensation to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
Graham number | 100.09 | 111.91 | 160.31 | 182.32 | 213.08 | |
ROIC | 0.24 | 0.21 | 0.36 | 0.42 | 0.34 | |
Return on tangible assets | 0.21 | 0.17 | 0.27 | 0.3 | 0.27 | |
Graham Net | 0.1 | -0.98 | -3.63 | -14.59 | -4.95 | |
Working capital | 6.19B | 7.69B | 8.12B | 7.72B | 9.04B | |
Tangible asset value | 3.02B | 3.53B | 4.4B | 4.66B | 6.42B | |
Net current asset value | 1.28B | 1.48B | 1.79B | 1.37B | 2.66B | |
Invested capital | 0.95 | 1.12 | 0.83 | 0.8 | 0.61 | |
Average receivables | 1.82B | 1.78B | 2.56B | 3.67B | 3.57B | |
Average payables | 443.77M | 484.47M | 711.05M | 920.46M | 1.01B | |
Average inventory | 1.71B | 1.72B | 2.29B | 3.33B | 4.39B | |
Days sales outstanding | 55.03 | 76.2 | 75.53 | 91.4 | 59.13 | |
Days payables outstanding | 25.96 | 39.78 | 38.72 | 39.45 | 38.24 | |
Days of inventory on hand | 106.16 | 127.58 | 125.51 | 154.75 | 182.14 | |
Receivables turnover | 6.63 | 4.79 | 4.83 | 3.99 | 6.17 | |
Payables turnover | 14.06 | 9.18 | 9.43 | 9.25 | 9.54 | |
Inventory turnover | 3.44 | 2.86 | 2.91 | 2.36 | 2 | |
ROE | 0.46 | 0.43 | 0.65 | 0.73 | 0.55 | |
Capex per share | -1.99 | -1.4 | -2.43 | -3.9 | -3.7 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-25 for Q4
Metric | History | 2022-06-26 | 2022-09-25 | 2022-12-25 | 2023-03-26 | 2023-06-25 |
---|---|---|---|---|---|---|
Revenue per share | 33.59 | 37.07 | 38.8 | 28.68 | 23.93 | |
Net income per share | 8.76 | 10.42 | 10.8 | 6.03 | 5.99 | |
Operating cash flow per share | 3.22 | 8.69 | 8.38 | 12.8 | 8.38 | |
Free cash flow per share | 2.31 | 7.67 | 7.18 | 11.91 | 7.79 | |
Cash per share | 26.51 | 31.97 | 33.73 | 39.8 | 40.09 | |
Book value per share | 45.5 | 54.15 | 61.06 | 62.31 | 61.25 | |
Tangible book value per share | 33.78 | 42.28 | 47.78 | 48.96 | 47.89 | |
Share holders equity per share | 45.5 | 54.15 | 61.06 | 62.31 | 61.25 | |
Interest debt per share | 36.61 | 36.89 | 37.13 | 37.72 | 37.73 | |
Market cap | 62.07B | 50.85B | 56.06B | 66.89B | 83.16B | |
Enterprise value | 63.55B | 51.59B | 56.57B | 66.59B | 82.83B | |
P/E ratio | 12.84 | 8.91 | 9.54 | 20.54 | 25.9 | |
Price to sales ratio | 13.39 | 10.02 | 10.62 | 17.29 | 25.93 | |
POCF ratio | 139.81 | 42.74 | 49.16 | 38.75 | 74.07 | |
PFCF ratio | 195.07 | 48.45 | 57.39 | 41.63 | 79.65 | |
P/B Ratio | 9.89 | 6.86 | 6.75 | 7.96 | 10.13 | |
PTB ratio | 9.89 | 6.86 | 6.75 | 7.96 | 10.13 | |
EV to sales | 13.71 | 10.17 | 10.72 | 17.21 | 25.83 | |
Enterprise value over EBITDA | 40.55 | 29.09 | 32.04 | 59.74 | 87.4 | |
EV to operating cash flow | 143.16 | 43.37 | 49.62 | 38.57 | 73.78 | |
EV to free cash flow | 199.73 | 49.16 | 57.92 | 41.44 | 79.34 | |
Earnings yield | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
Debt to equity | 0.8 | 0.67 | 0.6 | 0.6 | 0.61 | |
Debt to assets | 0.29 | 0.27 | 0.26 | 0.26 | 0.27 | |
Net debt to EBITDA | 0.95 | 0.42 | 0.29 | -0.27 | -0.34 | |
Current ratio | 2.69 | 2.69 | 3.01 | 3.09 | 3.16 | |
Interest coverage | 32 | 36.87 | 36.01 | 11.2 | 18.37 | |
Income quality | 0.37 | 0.83 | 0.78 | 2.12 | 1.4 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.17 | 0.14 | 0.16 | 0.29 | 0.29 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.09 | 0.09 | 0.09 | 0.11 | 0.13 | |
Intangibles to total assets | 0.09 | 0.09 | 0.09 | 0.09 | 0.1 | |
Capex to operating cash flow | -0.28 | -0.12 | -0.14 | -0.07 | -0.07 | |
Capex to revenue | -0.03 | -0.03 | -0.03 | -0.03 | -0.02 | |
Capex to depreciation | -1.43 | -1.85 | -1.91 | -1.3 | -0.88 | |
Stock based compensation to revenue | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
Graham number | 94.7 | 112.65 | 121.78 | 91.97 | 90.83 | |
ROIC | 0.12 | 0.12 | 0.11 | 0.06 | 0.06 | |
Return on tangible assets | 0.08 | 0.08 | 0.08 | 0.05 | 0.05 | |
Graham Net | -14.79 | -9.67 | -6.26 | -4.29 | -5.01 | |
Working capital | 7.72B | 8.56B | 9.16B | 9.29B | 9.04B | |
Tangible asset value | 4.66B | 5.79B | 6.5B | 6.61B | 6.42B | |
Net current asset value | 1.37B | 2.3B | 2.81B | 2.89B | 2.66B | |
Invested capital | 0.8 | 0.67 | 0.6 | 0.6 | 0.61 | |
Average receivables | 4.01B | 4.44B | 4.32B | 3.67B | 3.04B | |
Average payables | 1.01B | 1.08B | 1.03B | 760.67M | 536.32M | |
Average inventory | 3.72B | 4.16B | 4.59B | 4.85B | 4.85B | |
Days sales outstanding | 83.75 | 81.05 | 69.41 | 75.87 | 79.23 | |
Days payables outstanding | 35.9 | 37.69 | 28.52 | 23.93 | 24.22 | |
Days of inventory on hand | 140.81 | 143.36 | 149.52 | 194.07 | 247.81 | |
Receivables turnover | 1.07 | 1.11 | 1.3 | 1.19 | 1.14 | |
Payables turnover | 2.51 | 2.39 | 3.16 | 3.76 | 3.72 | |
Inventory turnover | 0.64 | 0.63 | 0.6 | 0.46 | 0.36 | |
ROE | 0.19 | 0.19 | 0.18 | 0.1 | 0.1 | |
Capex per share | -0.91 | -1.02 | -1.2 | -0.89 | -0.59 |
LRCX Frequently Asked Questions
What is Lam Research Corporation stock symbol ?
Lam Research Corporation is a US stock , located in Fremont of Ca and trading under the symbol LRCX
Is Lam Research Corporation buy or a sell ?
28 stock analysts have 28 predictions with a medium analyst target price of $655.96. The lowest prediction is $400 and the highest is $869
What is LRCX stock prediction ?
What is Lam Research Corporation stock quote today ?
Lam Research Corporation stock price is $629.955 today.
Is Lam Research Corporation stock public?
Yes, Lam Research Corporation is a publicly traded company.